FOI 1727 – Non small cell lung cancer

Response

Date: 22 December 2022

FREEDOM OF INFORMATION – DECISION NOTICE

Dear Sir / Madam,

FOI Reference Number: 1727

Question 1
Does NHS Derby and Derbyshire ICB have any local treatment guidelines/pathways/protocols/algorithms for the treatment of non-small cell lung cancer?
If Yes please provide a copy.

Question 2
Does NHS Derby and Derbyshire ICB have protocols for the use of the following targeted drug therapies in the treatment of non-small cell lung cancer?

Sotorasib (Lumykras)
Entrectinib (Rozlytrek)
Larotrectinib (Vitrakvi)
Dabrafenib (Tafinlar)
Trametinib (Mekinist)
Capmatinib (Tabrecta)
Tepotinib (Tepmetko)
Bevacizumab (Avastin)
Ramucirumab (Cyramza)
Atezolizumab (Tecentriq)
Durvalumab (Imfinzi)
Cemiplimab- (Libtayo)
Nivolumab (Opdivo)
Pembrolizumab (Keytruda)
Ipilimumab (Yervoy)
Afatinib (Giotrif)
Dacomitinib (Vizimpro)
Erlotinib (Tarceva)
Gefitinib (Iressa)
Osimertinib (Tagrisso)
Amivantamab (Rybrevant)
Mobocertinib (Exkivity)
trastuzumab deruxtecan (Enhertu)
Alectinib (Alecensa)
Brigatinib (Alunbrig)
Ceritinib (Zykadia)
Crizotinib (Xalkori)
Lorlatinib (Lorviqua )
Entrectinib (Rozlytrek)
Pralsetinib (Gavreto)
Selpercatinib (Retsevmo)
Nintedanib (Vargatef®)

Question 3
If a local protocol for the use of Sotorasib (Lumykras) for the treatment of non-small cell lung cancer is available please could a copy be provided?

Question 4
Does NHS Derby and Derbyshire ICB have any local pathways/protocols/guidelines for the use of molecular biomarker testing in diagnosis/treatment of non-small cell lung cancer?

Question 5
Is NHS Derby and Derbyshire ICB part of a Cancer alliance or network, if so which ones?

Our response:

Q1-4: No.

Q5. Yes; the East Midlands Cancer Alliance.

I hope that this answers your queries with the information we currently hold, but if I can be of any further assistance please do not hesitate to contact me.

If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date of receipt of the response to your original letter and should be addressed to:

NHS Derby and Derbyshire ICB
FOI Team
Scarsdale
Nightingale Close
Newbold
Chesterfield
S41 7PF

Or:

ddicb.foi@nhs.net

If you are not content with the outcome of our review, you may apply directly to the Information Commissioner for a decision. Generally, the ICO cannot make a decision unless you have exhausted the complaints procedure provided by the Derby and Derbyshire Integrated Care Board (ICB).

The Information Commissioner can be contacted at: Information Commissioners Office, Wycliffe House, Water Lane, Wilmslow, Cheshire SK9 5AF, telephone 0303 123 1113, email casework@ico.org.uk.

Yours faithfully,

Kathryn Jacklin
FOI Officer
Derby and Derbyshire ICB

All information we have provided is subject to the provisions of the Re-use of Public Sector Information Regulations 2015. Accordingly, if the information has been made available for re-use under the Open Government Licence (OGL) a request to re-use is not required, but the licence conditions must be met. You must not re-use any previously unreleased information without having the consent from the ICB. Should you wish to re-use previously unreleased information then you must make your request in writing (email will suffice) to the FOI Lead via ddicb.foi@nhs.net. All requests for re-use will be responded to within 20 working days of receipt.